Ocular biometric parameters and myopia severity in Ghana: A cross-sectional analysis in a young clinical sample

AJO International · Available online 6 Aug 2026 · In press · Journal article · DOI 10.1016/j.ajoint.2026.100297

Free full text

Authors (6)

Stephen Ocansey, Ebenezer Nana Kojo Bondzie Ghartey, Ebenezer Oduro Antiri, Emmanuel Essien, Fuseina Safianu, Emmanuel Kwasi Abu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Volume

3

Issue

3

Pages

100297

Year

2026

Citation

Ocansey, S., Ghartey, E., Antiri, E., et al. (2026). Ocular biometric parameters and myopia severity in Ghana: A cross-sectional analysis in a young clinical sample. AJO International. https://doi.org/10.1016/j.ajoint.2026.100297

Related articles

• Impact of international binocular visual field pass criteria on Esterman-based licensing classification · AJO International · 2026 · Same journal
• Demographics and distribution of intravitreal injections in the pediatric age group between 2008 and 2025 · AJO International · 2026 · Same journal
• Comment on early response and interval extension after switching to aflibercept 8 mg in treated neovascular AMD or pachychoroid-related MNV · AJO International · 2026 · Same journal
• Early real-world anatomic response and interval extension after switching to aflibercept 8 mg in previously treated eyes with neovascular AMD or pachychoroid-related macular neovascularization · AJO International · 2026 · Same journal
• Retinoblastoma in Rwanda: infant onset is associated with bilateral disease and improved survival · AJO International · 2026 · Same journal
• Anterior segment findings from community outreach screening in Timor-Leste using the smart eye camera: A pilot telemedicine feasibility study · AJO International · 2026 · Same journal
• A Tribute to Charles L. Schepens, Twenty Years On · AJO International · 2026 · Same journal
• Apple Vision Pro as a wearable display for endoscopic dacryocystorhinostomy: Surgical experience, efficiency, and cost · AJO International · 2026 · Same journal
• Response to comment on early response and interval extension after switching to aflibercept 8 mg in treated neovascular AMD or pachychoroid-related MNV · AJO International · 2026 · Same journal
• Diabetic retinopathy in Querétaro, Mexico: A subset analysis of the RAAB survey 2025 · AJO International · 2026 · Same journal